• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新发传染病,关注感染预防、环境生存和杀菌剂敏感性:SARS-CoV-2、猴痘和耳念珠菌。

Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris.

机构信息

Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC; Department of Infection Prevention, UNC Medical Center, Chapel Hill, NC; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.

Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC.

出版信息

Am J Infect Control. 2023 Nov;51(11S):A22-A34. doi: 10.1016/j.ajic.2023.02.006.

DOI:10.1016/j.ajic.2023.02.006
PMID:37890950
Abstract

BACKGROUND

New and emerging infectious diseases continue to represent a public health threat. Emerging infectious disease threats include pathogens increasing in range (eg, Mpox), zoonotic microbes jumping species lines to cause sustained infections in humans via person-to-person transmission (SARS-CoV-2) and multidrug-resistant pathogens (eg, Candida auris).

MATERIALS AND METHODS

We searched the published English literature and reviewed the selected articles on SARS-CoV-2, Mpox, and Candida auris with a focus on environmental survival, contamination of the patient's hospital environment, susceptibility of the pathogen to antiseptics and disinfectants and infection prevention recommendations.

RESULTS

All three pathogens (ie, SARS-CoV-2, Mpox, and Candida auris) can survive on surfaces for minutes to hours and for Mpox and C auris for days. Currently available antiseptics (eg, 70%-90% alcohol hand hygiene products) are active against SARS-CoV-2, Mpox and C auris. The U.S Environmental Protection Agency provides separate lists of surface disinfectants active against SARS-CoV-2, Mpox, and C auris.

DISCUSSION

The risk of environment-to-patient transmission of SARS-CoV-2, Mpox and Candida auris, is very low, low-moderate and high, respectively. In the absence of appropriate patient isolation and use of personal protection equipment, the risk of patient-to-health care provider transmission of SARS-CoV-2, Mpox, and C auris is high, moderate and low, respectively.

CONCLUSIONS

Appropriate patient isolation, use of personal protective equipment by health care personnel, hand hygiene, and surface disinfection can protect patients and health care personnel from acquiring SARS-CoV-2, Mpox, and C auris from infected patients.

摘要

背景

新出现和新出现的传染病继续构成公共卫生威胁。新出现的传染病威胁包括病原体传播范围扩大(例如,猴痘)、人畜共患病微生物跨越物种界限,通过人与人之间的传播在人类中引起持续感染(SARS-CoV-2)和多药耐药病原体(例如,耳念珠菌)。

材料和方法

我们搜索了已发表的英文文献,并对 SARS-CoV-2、猴痘和耳念珠菌的选定文章进行了综述,重点关注环境生存能力、患者医院环境的污染、病原体对防腐剂和消毒剂的敏感性以及感染预防建议。

结果

所有三种病原体(即 SARS-CoV-2、猴痘和耳念珠菌)都可以在表面存活数分钟到数小时,而猴痘和耳念珠菌则可以存活数天。目前可用的防腐剂(例如,70%-90%酒精手部卫生产品)对 SARS-CoV-2、猴痘和耳念珠菌有效。美国环境保护署提供了针对 SARS-CoV-2、猴痘和耳念珠菌的表面消毒剂的单独清单。

讨论

SARS-CoV-2、猴痘和耳念珠菌从环境传播到患者的风险非常低、低-中度和高,分别。在没有适当的患者隔离和使用个人防护设备的情况下,SARS-CoV-2、猴痘和耳念珠菌从患者传播到医护人员的风险分别为高、中、低。

结论

适当的患者隔离、医护人员使用个人防护设备、手部卫生和表面消毒可以保护患者和医护人员免受感染患者的 SARS-CoV-2、猴痘和耳念珠菌感染。

相似文献

1
Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris.新发传染病,关注感染预防、环境生存和杀菌剂敏感性:SARS-CoV-2、猴痘和耳念珠菌。
Am J Infect Control. 2023 Nov;51(11S):A22-A34. doi: 10.1016/j.ajic.2023.02.006.
2
Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities.耳念珠菌和白念珠菌对医疗机构中使用的 21 种杀真菌剂的敏感性。
Infect Control Hosp Epidemiol. 2019 Mar;40(3):380-382. doi: 10.1017/ice.2019.1. Epub 2019 Feb 15.
3
: Disinfectants and Implications for Infection Control.消毒剂及其对感染控制的影响
Front Microbiol. 2018 Apr 12;9:726. doi: 10.3389/fmicb.2018.00726. eCollection 2018.
4
Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions.控制可能爆发的耳念珠菌感染:多项干预措施的经验教训。
J Hosp Infect. 2017 Dec;97(4):363-370. doi: 10.1016/j.jhin.2017.09.009. Epub 2017 Sep 19.
5
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.实验室调查、管理以及感染预防和控制:一篇叙述性综述,旨在为 2024 年英格兰国家指南更新提供信息。
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
6
Different efficacies of common disinfection methods against candida auris and other candida species.常见消毒方法对耳念珠菌和其他念珠菌属种的不同杀菌效果。
J Infect Public Health. 2020 May;13(5):730-736. doi: 10.1016/j.jiph.2020.01.008. Epub 2020 Jan 28.
7
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.在 2019 冠状病毒病大流行期间预防和控制耐多药生物体和耳念珠菌爆发的挑战:耐碳青霉烯鲍曼不动杆菌爆发报告和文献系统评价。
Antimicrob Resist Infect Control. 2022 Jan 21;11(1):12. doi: 10.1186/s13756-022-01052-8.
8
The first case of clade I Candida auris candidemia in a patient with COVID-19 in Japan.日本首例 COVID-19 患者感染谱系 I 耳念珠菌血症。
J Infect Chemother. 2023 Jul;29(7):713-717. doi: 10.1016/j.jiac.2023.03.018. Epub 2023 Mar 29.
9
Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients.耳念珠菌和多重耐药菌病原体在定植患者附近的快速环境污染。
Clin Infect Dis. 2024 May 15;78(5):1276-1284. doi: 10.1093/cid/ciad752.
10
Emerging strategies for environmental decontamination of the nosocomial fungal pathogen .新兴的医院真菌病原体环境净化策略。
J Med Microbiol. 2022 Jun;71(6). doi: 10.1099/jmm.0.001548.

引用本文的文献

1
Clinical Isolate of from a Patient in North Carolina: Identification, Whole-Genome Sequence Analysis, and Anticandidal Activity of .来自北卡罗来纳州一名患者的临床分离株:的鉴定、全基因组序列分析及抗念珠菌活性 。 (你提供的原文中部分内容缺失,不太完整准确,这是按照现有内容尽量完整翻译的结果)
Open J Med Microbiol. 2025 Mar;15(1):11-35. doi: 10.4236/ojmm.2025.151002. Epub 2025 Mar 5.
2
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1.Dm-CVNH的分离与结构解析,一种对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和人类免疫缺陷病毒1型(HIV-1)具有活性的新型氰苷蛋白N(cyanovirin-N)同源物。
J Biol Chem. 2025 Mar;301(3):108319. doi: 10.1016/j.jbc.2025.108319. Epub 2025 Feb 14.
3
Variable sensitivity of clinical Candida auris strains to Biocides: implications for infection control in Healthcare Settings.
临床假丝酵母菌菌株对消毒剂的可变敏感性:对医疗机构感染控制的影响。
BMC Microbiol. 2024 Nov 4;24(1):447. doi: 10.1186/s12866-024-03605-w.
4
CRISPR-based strategies for sample-to-answer monkeypox detection: current status and emerging opportunities.基于 CRISPR 的样本到答案猴痘检测策略:现状和新机遇。
Nanotechnology. 2024 Nov 4;36(4):042001. doi: 10.1088/1361-6528/ad892b.
5
Prediction of potential public health risk of the recent multicountry monkeypox outbreak: An update after the end declaration of global public health emergency.近期多国猴痘疫情潜在公共卫生风险的预测:全球突发公共卫生事件结束声明发布后的最新情况
Health Sci Rep. 2024 May 29;7(6):e2136. doi: 10.1002/hsr2.2136. eCollection 2024 Jun.
6
The role of environmental and healthcare-associated infections in Asia: Lessons learned from the coronavirus disease 2019 (COVID-19) pandemic.环境及医疗保健相关感染在亚洲的作用:从2019冠状病毒病(COVID-19)大流行中吸取的教训
Antimicrob Steward Healthc Epidemiol. 2023 Jun 15;3(1):e100. doi: 10.1017/ash.2023.182. eCollection 2023.